Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dillner

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|June 15, 1990
Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinomaY T Foong, H M Cheng, C K Sam, et al.
International Journal of Cancer|February 15, 1986
The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigensJ Dillner, B Kallin, B Ehlin-Henriksson, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Squamous cell carcinoma of the penis: premalignant lesionsS Horenblas, G von Krogh, A L Cubilla, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasiaJ Dillner, L Dillner, J Robb, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1995
Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinomaH M Cheng, Y T Foong, A J AbuSamah, et al.
International Journal of Cancer|November 15, 1986
Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigenI Ernberg, B Kallin, J Dillner, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1993
No evidence of HPV in epidemic and endemic Kaposi's sarcomaE E Kaaya, A Voevodin, P Szalecki, et al.
Cancer Causes & Control : CCC|May 1, 1993
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective studyT Lehtinen, J Lumio, J Dillner, et al.
Neurology|June 24, 2004
An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective studyP Sundström, P Juto, G Wadell, et al.
The Journal of General Virology|June 1, 1995
The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopesR Tedeschi, Y T Foong, H M Cheng, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|June 15, 1990
Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinomaY T Foong, H M Cheng, C K Sam, et al.
International Journal of Cancer|February 15, 1986
The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigensJ Dillner, B Kallin, B Ehlin-Henriksson, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Squamous cell carcinoma of the penis: premalignant lesionsS Horenblas, G von Krogh, A L Cubilla, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasiaJ Dillner, L Dillner, J Robb, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1995
Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinomaH M Cheng, Y T Foong, A J AbuSamah, et al.
International Journal of Cancer|November 15, 1986
Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigenI Ernberg, B Kallin, J Dillner, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1993
No evidence of HPV in epidemic and endemic Kaposi's sarcomaE E Kaaya, A Voevodin, P Szalecki, et al.
Cancer Causes & Control : CCC|May 1, 1993
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective studyT Lehtinen, J Lumio, J Dillner, et al.
Neurology|June 24, 2004
An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective studyP Sundström, P Juto, G Wadell, et al.
The Journal of General Virology|June 1, 1995
The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopesR Tedeschi, Y T Foong, H M Cheng, et al.
Pageof 17